The Lynx Group

Kristin Siyahian


Authored Items

A Breakthrough Treatment for ALL and CLL: The New Biologic Agent, CTL019

An Interview With David L. Porter, MD, of the University of Pennsylvania

May 2014, Vol 3, No 3 - Interview with the Innovators

David L. Porter, MD, is Jodi Fisher Horowitz Professor in Leukemia Care Excellence in the Perelman School of Medicine at the University of Pennsylvania; and Director, Blood and Marrow Transplantation at the Abramson Cancer Center.The number of patients was small and the therapy still investigational, but the results of research [ Read More ]

Sign me up!